MedTrace Logo

Implementation of the MOX Activity Monitor in Hospitalized Geriatric Rehabilitation

NCT07124247 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-08-15

No results posted yet for this study

Summary

Staying active is essential for healthy aging, but hospitalized older adults in rehabilitation often move very little. This study explores how much physical activity these patients actually get and how it relates to their recovery. Using the MOX activity monitor-a device that accurately tracks walking, standing, and sedentary time-the study aims to better understand daily activity patterns during rehabilitation.

Researchers will test the best way to use the MOX monitor, develop a standard protocol for its use, and integrate its data into patients' electronic health records. By comparing MOX activity data with standard measures of physical performance, the study will determine how useful activity monitoring is for tracking recovery in older patients. This could lead to improved care and more personalized rehabilitation plans in the future.

Conditions

  • Hip Fracture
  • Stroke
  • Fraility

Interventions

DEVICE

Activity registration for one week with an activity monitor (MOX1)

The participants will be equipped with the MOX activity monitor, which will be attached to the thigh. The device is waterproof, allowing participants to shower and swim, and does not require recharging during the study period. The MOX will be attached on the same day as the BBS and Handgrip strength measurements, which will take place on a Friday. The following Monday, the 10mWT will be conducted, thus within the same week that the MOX is attached. The MOX monitor will be worn for one week.

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    collaborator OTHER

  • KU Leuven

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-08
Primary Completion
2026-03-01
Completion
2026-07-01

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07124247 on ClinicalTrials.gov